Journal of Diabetes and Its Complications
Volume 17, Issue 2 , Pages 78-81 , March 2003

Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients

Received 28 March 2002 ,Revised 2 June 2002 ,Accepted 19 June 2002.

References 

  1. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care. 1997;20:1822–1826
  2. Buse JB, Hroscikoski M. The case for a role for postprandial glucose monitoring in diabetes management. Journal of Family Practice. 1998;47:S29–S36Supplement
  3. Ceriello A. The emerging role of post-prandial hyperglycemic spikes in the pathogenesis of diabetic complications. Diabetic Medicine. 1998;15:188–193
  4. Jones SC, Saunders HJ, Qi W, Pollock CA. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia. 1999;42:1113–1119
  5. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18:258–268
  6. Li W, Liu X, Yanoff M, Cohen S, Ye X. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia. 1996;39:537–547
  7. Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna R, Moghetti P, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients. Diabetes Care. 2000;23:45–50
  8. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the development of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Research and Clinical Practice. 1995;28:103–117
  9. Perrott RL, North RV, Drasdo N, Ahmed KA, Owens DR. The influence of plasma glucose upon pulsatile ocular blood flow in subjects with type II diabetes mellitus. Diabetologia. 2001;44:700–705
  10. Service FJ, O'Brien PC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia. 2001;44:1215–1220
  11. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329:977–986
  12. The Diabetes Control and Complications Trial Research Group . The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44:968–983
  13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  14. UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  15. Voutilainen-Kaunisto R, Teräsvirta M, Uusitupa M, Niskanen L. Occurrence and predictors of retinopathy and visual acuity in type 2 diabetic patients and control subjects 10 year follow-up from the diagnosis. Journal of Diabetes and Its Complications. 2001;15:24–33
  16. Zhang L, Krzetowski G, Albert A, Lefebvre P. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24:1275–1279

PII: S1056-8727(02)00197-6

Journal of Diabetes and Its Complications
Volume 17, Issue 2 , Pages 78-81 , March 2003

Article Tools

* Image Usage & Resolution